Paclitaxel pharmacokinetics, threshold models, and dosing strategies.

Suppr

超能文献

作者信息

Sparreboom Alex, Verweij Jaap

出版信息

J Clin Oncol. 2003 Jul 15;21(14):2803-4; author reply 2805-6. doi: 10.1200/JCO.2003.99.038.

DOI:10.1200/JCO.2003.99.038

PMID:12860961

Abstract

摘要

相似文献

Paclitaxel pharmacokinetics, threshold models, and dosing strategies.

J Clin Oncol. 2003 Jul 15;21(14):2803-4; author reply 2805-6. doi: 10.1200/JCO.2003.99.038.

Paclitaxel pharmacokinetics, threshold models, and dosing strategies.

J Clin Oncol. 2003 Jul 15;21(14):2804-5; author reply 2805-6. doi: 10.1200/JCO.2003.99.074.

A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules.

Clin Cancer Res. 2005 Nov 1;11(21):7834-40. doi: 10.1158/1078-0432.CCR-05-0803.

Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.

Clin Cancer Res. 2004 Dec 15;10(24):8325-31. doi: 10.1158/1078-0432.CCR-04-1078.

Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumours.

Eur J Cancer. 2004 Mar;40(5):681-8. doi: 10.1016/j.ejca.2003.11.027.

Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel.

Clin Cancer Res. 2008 Sep 15;14(18):5856-63. doi: 10.1158/1078-0432.CCR-08-1046.

Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.

Clin Cancer Res. 2007 Jun 1;13(11):3293-301. doi: 10.1158/1078-0432.CCR-06-2496.

A simplified premedication schedule for 1-hour paclitaxel administration.

J Support Oncol. 2005 Jan-Feb;3(1):77-81.

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

J Clin Oncol. 2005 Nov 1;23(31):7785-93. doi: 10.1200/JCO.2004.00.6148.

Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process.

Drug Dev Ind Pharm. 2011 Jun;37(6):628-37. doi: 10.3109/03639045.2010.533682. Epub 2011 Mar 14.

引用本文的文献

Genome-wide conditional association study reveals the influences of lifestyle cofactors on genetic regulation of body surface area in MESA population.

PLoS One. 2021 Jun 18;16(6):e0253167. doi: 10.1371/journal.pone.0253167. eCollection 2021.

A Framework for Analyzing the Whole Body Surface Area from a Single View.

PLoS One. 2017 Jan 3;12(1):e0166749. doi: 10.1371/journal.pone.0166749. eCollection 2017.

Effect of age on drug metabolism in women with breast cancer.

Expert Opin Drug Metab Toxicol. 2015 May;11(5):757-66. doi: 10.1517/17425255.2015.1037277.

Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.

Cancer Chemother Pharmacol. 2011 Oct;68(4):827-33. doi: 10.1007/s00280-010-1509-4. Epub 2011 Jan 5.

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.

Br J Cancer. 2006 Oct 9;95(7):794-800. doi: 10.1038/sj.bjc.6603332. Epub 2006 Sep 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验